These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 3124801

  • 41. Antibiotic therapy of experimental Pseudomonas keratitis in guinea pigs.
    Davis SD, Sarff LD, Hyndiuk RA.
    Arch Ophthalmol; 1977 Sep; 95(9):1638-43. PubMed ID: 197908
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Michalová K, Moyes AL, Cameron S, Juni BA, Obritsch WF, Dvorak JA, Doughman DJ, Rhame FS.
    Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
    [Abstract] [Full Text] [Related]

  • 44. [Treatment of Pseudomonas aeruginosa keratitis with tobramycin and gentamicin: animal experiments (author's transl)].
    Behrens-Baumann W, Paul HH, Ansorg R.
    Klin Monbl Augenheilkd; 1981 Mar; 178(3):197-9. PubMed ID: 7230715
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Cryotherapy for experimental Pseudomonas keratitis.
    Alpren TV, Hyndiuk RA, Davis SD, Sarff LD.
    Arch Ophthalmol; 1979 Apr; 97(4):711-4. PubMed ID: 426689
    [Abstract] [Full Text] [Related]

  • 47. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS, Romanowski EG, Kowalski RP, Yates KA, Gordon YJ.
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [Abstract] [Full Text] [Related]

  • 48. Pharmacokinetics and safety of transcorneal iontophoresis of tobramycin in the rabbit.
    Rootman DS, Jantzen JA, Gonzalez JR, Fischer MJ, Beuerman R, Hill JM.
    Invest Ophthalmol Vis Sci; 1988 Sep; 29(9):1397-401. PubMed ID: 3417424
    [Abstract] [Full Text] [Related]

  • 49. In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.
    Tajima K, Miyake T, Koike N, Hattori T, Kumakura S, Yamaguchi T, Matsumoto T, Fujita K, Kuroda M, Ito N, Goto H.
    J Infect Chemother; 2014 Jun; 20(6):343-9. PubMed ID: 24726376
    [Abstract] [Full Text] [Related]

  • 50. Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis.
    Hobden JA, O'Callaghan RJ, Hill JM, Hagenah M, Insler MS, Reidy JJ.
    Curr Eye Res; 1992 Mar; 11(3):259-65. PubMed ID: 1587148
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS, Denton P, Osterhout GJ, Tuli S, O'Brien TP.
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [Abstract] [Full Text] [Related]

  • 54. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
    Oguz H, Ozbilge H, Oguz E, Gurkan T.
    Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
    [Abstract] [Full Text] [Related]

  • 55. Topical imipenem therapy of aminoglycoside-resistant Pseudomonas keratitis in rabbits.
    Sawusch MR, O'Brien TP, Valentine J, Dick JD, Gottsch JD.
    Am J Ophthalmol; 1988 Jul 15; 106(1):77-81. PubMed ID: 3164983
    [Abstract] [Full Text] [Related]

  • 56. Relative efficacy of the topical use of amikacin, gentamicin and tobramycin in experimental Pseudomonas keratitis.
    Davis SD, Sarff LD, Hyndiuk RA.
    Can J Ophthalmol; 1980 Jan 15; 15(1):28-9. PubMed ID: 6769572
    [Abstract] [Full Text] [Related]

  • 57. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
    Mannis MJ.
    Trans Am Ophthalmol Soc; 2002 Jan 15; 100():243-71. PubMed ID: 12545697
    [Abstract] [Full Text] [Related]

  • 58. The combination of topical ceftazidime and aminoglycosides in the treatment of refractory pseudomonal keratitis.
    Robinson A, Kremer I, Avisar R, Gaton D, Savir H, Yassur Y.
    Graefes Arch Clin Exp Ophthalmol; 1999 Mar 15; 237(3):177-80. PubMed ID: 10090578
    [Abstract] [Full Text] [Related]

  • 59. Neutrophil extracellular traps may have a dual role in Pseudomonas aeruginosa keratitis.
    Zhu B, Zhang L, Yuan K, Huang X, Hu R, Jin X.
    Eur J Clin Microbiol Infect Dis; 2021 Jan 15; 40(1):169-180. PubMed ID: 32875519
    [Abstract] [Full Text] [Related]

  • 60. The effectiveness of an improved combination therapy for experimental Staphylococcus aureus keratitis.
    Balzli CL, McCormick CC, Caballero AR, Tang A, O'Callaghan RJ.
    Adv Ther; 2010 Dec 15; 27(12):933-40. PubMed ID: 21046494
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.